Latest Brain tumor Stories
VAL-083 Anti-tumor Activity Is Consistently Superior to Temozolomide in Preclinical Models of Glioblastoma VANCOUVER, British Columbia, MENLO PARK, Calif., and MIAMI, Nov.
Builds Expert Independent Board As Company Advances Towards Late-Stage Brain Cancer Trials SAN DIEGO, Nov.
Continued Positive Trends in Overall Survival and Progression-Free Survival; LOS ANGELES, Nov. 14, 2014 /PRNewswire/ -- ImmunoCellular Therapeutics, Ltd.
Interim analysis of the pivotal phase III trial of Tumor Treating Fields in newly diagnosed glioblastoma (EF-14) will be presented as a late-breaking oral presentation ST.
VANCOUVER, British Columbia and MENLO PARK, Calif., Nov.
BETHESDA, Md., Nov. 7, 2014 /PRNewswire/ -- Northwest Biotherapeutics (NASDAQ: NWBO) ("NW Bio"), a U.S.
LOS ANGELES, Nov.
Proton beam radiation does not cause the serious side effects associated with conventional radiation for children with brain and spinal cancers. HOUSTON, Oct.
- The act of sweetening by admixture of some saccharine substance.